FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Gyroscope Announces Sanofi Equity Investment of up to $60 Million
The investment further validates the potential of Gyroscope’s gene therapy GT005 for the treatment of Geographic Atrophy, one of the world’s leading causes of blindness, and supports its ongoing Phase II development programs.
Biolinq Raises $100 Million, Unveils Micro-Sensing Technology in the Skin
This record private capital raise in the continuous glucose monitoring space includes participation from T&W Medical, AXA IM Alts, Global Health Investment Corporation, Ascensia Diabetes Care, Longevity Vision Fund, Falcon Edge Capital, Aphelion Capital, M Ventures, Hikma Ventures, Senvest, The Broe Group, Taisho Pharmaceutical, Cirrus Logic, EOFlow, Able Partners and the JDRF T1D Fund.
LightForce Orthodontics Secures $50 Million Series C Funding
“LightForce’s innovative approach to an industry that has lacked technological disruptiveness for the past 25 years is what initially attracted us to this investment opportunity,” said Wen Hsieh, partner, Kleiner Perkins.
New View Surgical, Inc. Closes $9M Series B Financing
The round was led by members of New York Angels with Corza Medical, Inc., IAG Capital Partners, Charleston Angels Partners, Ariel Savannah Angel Partners, Keiretsu Forum, Mid Atlantic Bio Angels (MABA) and SSIP, among others participating in the round.
Innoventric Ltd., Wins the Prestigious Horizon Europe Grant
Amir Danino, Founder and CEO, said: In the last decade structural heart interventions have become extremely complex and risky. This is manifested, among else, by the duration of these procedures and by their sub-optimal technical success rates.
iApotheca Healthcare Inc. Announces Closing of $470K Angel Funding Round
"Leva Capital is thrilled to announce the addition of iApotheca into our investment portfolio," said Eddie Gobran, Managing Partner. "Their strategy aligns with our vision of investing in health technology that will improve the healthcare experience for Canadians. We are confident in iApotheca's team to execute their strategy and deliver a great experience to pharmacies across Canada."
Exosystems Raises $3.9M Series A Funding
With the latest investments, Exosystems plans to expand clinical & technical capabilities to further develop the company's technology and overseas business.
Zerigo Health Raises $43 Million in Series B Funding
This round will allow Zerigo Health to respond to the increasing demand for its innovative connected chronic skin condition solution for the over 40 million Americans living with psoriasis, vitiligo, and eczema.
DentalMonitoring, the Leading AI-Based Dental Software Company, Announces a $150 Million Growth Financing, Reaching a Valuation Over $1 Billion
The round is led by a new investment of $90 million from Mérieux Equity Partners and $60 million from Vitruvian Partners, an existing financial investor, demonstrating confidence in the company’s ambitious plans.
Medical Device News Magazine
